The cattle reproductive hormones market is projected to grow from USD 3.4 billion in 2026 to USD 6.6 billion by 2036, at a CAGR of 6.9%. Prostaglandins will dominate with a 38.0% market share, while estrus synchronization will lead the applications segment with a 54.0% share.